carbon monoxide has been researched along with Actinic Reticuloid Syndrome in 2 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vreman, HJ | 2 |
| Lee, OK | 1 |
| Stevenson, DK | 2 |
1 trial available for carbon monoxide and Actinic Reticuloid Syndrome
| Article | Year |
|---|---|
Sn-protoporphyrin: a consideration of the first clinical trial in human neonates.
Topics: Carbon Monoxide; Clinical Trials as Topic; Heme Oxygenase (Decyclizing); Humans; Infant, Newborn; Ja | 1988 |
1 other study available for carbon monoxide and Actinic Reticuloid Syndrome
| Article | Year |
|---|---|
In vitro and in vivo characteristics of a heme oxygenase inhibitor: ZnBG.
Topics: Animals; Bilirubin; Body Water; Carbon Monoxide; Deuteroporphyrins; Heme Oxygenase (Decyclizing); Hu | 1991 |